Inactive Instrument

Other languages Curative Biotechnology, Inc. Other OTC

Equities

CTYX

US20786Q2093

Other languages

Unlock all the news: Be the first to know and act before the market!

Curative Biotechnology, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	07/05
Curative Biotechnology, Inc. Announces Nomination of Dr. Theresa Heah to Board of Directors	22/03
Curative Biotechnology, Inc. Announces Nomination of Dr. Theresa Heah to Board of Directors	08/01
Curative Biotechnology, Inc. has withdrawn its IPO in the amount of $7.999998 million.	25/11
Curative Biotechnology, Inc. Announces Nomination of Dr. Jeffrey Liebmann to Board of Directors	31/23/31
Curative Biotechnology, Inc. has withdrawn its IPO in the amount of $7.999998 million.	07/23/07
Curative Biotechnology, Inc. Announces Establishment of Japanese Subsidiary for Licensing Transactions and Asset Acquisitions	07/23/07
Curative Biotechnology Announces Establishment of Japanese Subsidiary for Licensing Transactions and Asset Acquisitions	06/23/06
Curative Biotechnology, Inc. Files Patent on Ophthalmic Formulation	24/23/24
Curative Biotechnology, Inc. Announces Completion of IND Enabling Reformulated Metformin HCL Eye Drop Study	05/23/05
Curative Biotechnology Announces Completion of IND Enabling Reformulated Metformin HCL Eye Drop Study	05/23/05
Curative Biotechnology, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	17/22/17
Curative Biotechnology, Inc. has filed an IPO in the amount of $7.999998 million.	07/22/07
Curative Biotechnology, Inc. has withdrawn its IPO in the amount of $8 million.	31/22/31
Curative Biotechnology Announces Intent to Uplist to NYSE American Exchange	27/22/27
Curative Biotechnology Announces Intent to Uplist to NYSE American Exchange	27/22/27
Curative Biotechnology, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	01/22/01
Curative Biotechnology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	30/22/30
Curative Biotechnology Inc. Adds Biotech Veteran Lawrence S. Zaslow to Board of Directors	16/22/16
Curative Biotechnology Inc. Adds Biotech Veteran Lawrence S. Zaslow to Board of Directors	16/22/16

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Curative Biotechnology, Inc. Other OTC

Equities

CTYX

US20786Q2093

Other languages

Filters